Stay updated on TALEN/CRISPR in HPV CIN1 Clinical Trial
Sign up to get notified when there's something new on the TALEN/CRISPR in HPV CIN1 Clinical Trial page.
Latest updates to the TALEN/CRISPR in HPV CIN1 Clinical Trial page
- Check4 days agoChange DetectedFooter updates: Revision: v3.3.3 has been added; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed as part of site-wide version changes.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded the field 'Product manufactured in and exported from the U.S.: No' and updated the revision to v3.3.2. These are administrative metadata updates that do not impact trial content.SummaryDifference0.1%
- Check40 days agoChange DetectedRemoved the funding/operating status notice at the top of the page. Core trial data, including study description, eligibility criteria, interventions, and contacts, were not changed.SummaryDifference0.4%
- Check55 days agoChange DetectedThe page shows a UI redesign with updated layout and styling, while core trial information—title, eligibility criteria, outcomes, and enrollment—appears unchanged.SummaryDifference0.1%
- Check83 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference5%
- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
Stay in the know with updates to TALEN/CRISPR in HPV CIN1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TALEN/CRISPR in HPV CIN1 Clinical Trial page.